0001235802-21-000055.txt : 20210617
0001235802-21-000055.hdr.sgml : 20210617
20210617160620
ACCESSION NUMBER: 0001235802-21-000055
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210615
FILED AS OF DATE: 20210617
DATE AS OF CHANGE: 20210617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STANKOVICH THOMAS
CENTRAL INDEX KEY: 0001181166
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33818
FILM NUMBER: 211024745
MAIL ADDRESS:
STREET 1: 1001 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ReShape Lifesciences Inc.
CENTRAL INDEX KEY: 0001371217
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 481293684
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1001 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
BUSINESS PHONE: 9494296680
MAIL ADDRESS:
STREET 1: 1001 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
FORMER COMPANY:
FORMER CONFORMED NAME: EnteroMedics Inc
DATE OF NAME CHANGE: 20060802
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2021-06-15
0
0001371217
ReShape Lifesciences Inc.
RSLS
0001181166
STANKOVICH THOMAS
1001 CALLE AMANECER
SAN CLEMENTE
CA
92673
0
1
0
0
Chief Financial Officer
Common Stock, $0.001 par value per share
2021-06-15
4
D
0
4635
3.05
D
0
D
Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, Obalon Therapeutics, Inc. ("Obalon"), and Optimus Merger Sub, Inc., which became effective on June 15, 2021, in exchange for 2,613 shares of common stock of Obalon having a market value of $3.05 per share at the effective time of the merger.
/s/ Thomas Stankovich
2021-06-17